EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, SeaStar Medical Holding's Enterprise Value is $37.75 Mil.
SeaStar Medical Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-10.29 Mil. Therefore, SeaStar Medical Holding's EV-to-FCF for today is -3.67.
The historical rank and industry rank for SeaStar Medical Holding's EV-to-FCF or its related term are showing as below:
ICU'
s EV-to-FCF Range Over the Past 10 Years
Min: -9.41 Med: 0 Max: 0
Current: -3.69
ICU's EV-to-FCF is ranked worse than 100% of 378
companies
in the Biotechnology industry
Industry Median: 7.545
vs ICU: -3.69
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of SeaStar Medical Holding's EV-to-FCF
For the Biotechnology subindustry, SeaStar Medical Holding's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SeaStar Medical Holding's EV-to-FCF Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, SeaStar Medical Holding's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where SeaStar Medical Holding's EV-to-FCF falls into.
SeaStar Medical Holding's current Enterprise Value is $37.75 Mil.
SeaStar Medical Holding's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.29 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SeaStar Medical Holding (NAS:ICU) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
SeaStar Medical Holding's PE Ratio for today is calculated as:
SeaStar Medical Holding's share price for today is $0.375.
SeaStar Medical Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.227.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
SeaStar Medical Holding EV-to-FCF Related Terms
Thank you for viewing the detailed overview of SeaStar Medical Holding's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
SeaStar Medical Holding (SeaStar Medical Holding) Business Description
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ICU has been successfully added to your 